Skip to main content
Fascinating case series - which suggests potential reasons to include a PSCK9 inhibitor in a statin-associated necrotizing myopathy — due to these meds possibly lowering HMGCR levels. https://t.co/Jblf2EDNmp
Paul Sufka, MD
May-09-2019
×